
		Search for:

UMDNJ technologies available for licensing

Therapeutics

Combined Therapeutics Summaries

Uracil DNA Metabolism as a Target for Chemotherapy

Novel Bi-Functional Alpha-Kinases Protein Kinases linked to Ion Channels

Hematopoietic Growth Factor Inducible Neurokinin-1 Gene

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) An Antimitogenic Signal for Neuronal Precursor Cells

A New Therapeutic Approach for the Modulation of Serum Cholesterol Levels

A Novel strategy to Inhibit Replication of RNA Viruses

A Novel Topoisomerase 1 Binding Protein for Use in Cancer Diagnostics and Cancer Therapeutics

Induction of Oral Tolerance in Ulcerative Colitis and Crohn’s Disease

A Novel Antisense Strategy for Anti-Retroviral Intervention

Methods for Facilitating Vascular Growth in Cardiovascular Muscle

Computational Methods for the Discovery of Novel Inotropic Agents for the Treatment of Cardiovascular Diseases

Oligonucleotide Compositions for the inhibition of Transcription Factors

PNA-Neamine Conjugates for use as Therapeutic agents and Research Tools

Novel Combretastatin A-4 Analogues with Potent Cytotoxicity and Anti-Tubulin Polymerization Activities

Novel Modification of Immunomodulatory Protein

New Drug Combination for the Treatment of Viral Diseases

Human Preprotachykinin-I Gene Promoter

A New Superfamily of Protein Kinases

Compositions and Methods for the Treatment of Diseases associated with Faulty Cholesterol Regulation

Identification of a Myeloid Precursor Cell for Modulations of Immune Responses

Suppression of Nitric Oxide Production by Osteopontin

Identification of a Myeloid Precursor Cell for Modulations of Immune Responses

OPL News Items

11-7-07- The New Jersey Technology Counsel (NJTC) N.J. Regional Commercialization Conference... is happening on November 30th, 2007. Refer to the NJTC website for announcement and details regarding this important event

10-20-07- Dr. Kiran Madura Receives Funding UMDNJ facility member and CSO of UMDNJ start-up CellXplore, Dr. Kiran Madura has received a funding commitment from Foundation Venture Capital Group, LLC. Click HERE to read the article on UMDNJ's News page or HERE for an article from VentureMagazine.com

10-15-07- The Office of Patents& Licensing has moved... The OPL would like to thank all of the depts.that continue to provide logistic services during our move. We are now at One World's Fair Drive, Somerset, N.J, 08875

6-1-07- NJCST Grant Awards Info: The N.J. Comm. on Sci. and Tech.provided $5.7M in grant awards for various research activities. Click HERE for details from UMDNJ's News Page